ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $536,544 | -28.3% | 28,800 | 0.0% | 0.02% | -22.2% |
| Q2 2023 | $748,224 | -9.5% | 28,800 | 0.0% | 0.03% | -15.6% |
| Q1 2023 | $827,136 | -3.0% | 28,800 | 0.0% | 0.03% | -5.9% |
| Q4 2022 | $852,480 | +21.2% | 28,800 | -2.5% | 0.03% | +13.3% |
| Q3 2022 | $703,290 | +6.6% | 29,550 | 0.0% | 0.03% | +15.4% |
| Q2 2022 | $659,556 | +88788.9% | 29,550 | 0.0% | 0.03% | +8.3% |
| Q1 2022 | $742 | -99.9% | 29,550 | 0.0% | 0.02% | -25.0% |
| Q4 2021 | $1,059,000 | -15.8% | 29,550 | 0.0% | 0.03% | -23.8% |
| Q3 2021 | $1,258,000 | -4.1% | 29,550 | -2.5% | 0.04% | -4.5% |
| Q2 2021 | $1,312,000 | +11.7% | 30,300 | +5.2% | 0.04% | +4.8% |
| Q1 2021 | $1,175,000 | -13.7% | 28,800 | -4.2% | 0.04% | -17.6% |
| Q4 2020 | $1,361,000 | +24.9% | 30,060 | -2.4% | 0.05% | +13.3% |
| Q3 2020 | $1,090,000 | -6.2% | 30,800 | 0.0% | 0.04% | -16.7% |
| Q2 2020 | $1,162,000 | +30.6% | 30,800 | 0.0% | 0.05% | +10.2% |
| Q1 2020 | $890,000 | -44.3% | 30,800 | 0.0% | 0.05% | -27.9% |
| Q4 2019 | $1,597,000 | -5.6% | 30,800 | 0.0% | 0.07% | -11.7% |
| Q3 2019 | $1,691,000 | +35.2% | 30,800 | 0.0% | 0.08% | +35.1% |
| Q2 2019 | $1,251,000 | +34.4% | 30,800 | 0.0% | 0.06% | +29.5% |
| Q1 2019 | $931,000 | -12.8% | 30,800 | -3.1% | 0.04% | -22.8% |
| Q4 2018 | $1,068,000 | -21.6% | 31,800 | -1.5% | 0.06% | -8.1% |
| Q3 2018 | $1,362,000 | +31.8% | 32,300 | 0.0% | 0.06% | +21.6% |
| Q2 2018 | $1,033,000 | -35.6% | 32,300 | 0.0% | 0.05% | -36.2% |
| Q1 2018 | $1,605,000 | -7.8% | 32,300 | 0.0% | 0.08% | -1.2% |
| Q4 2017 | $1,741,000 | -7.0% | 32,300 | 0.0% | 0.08% | -12.0% |
| Q3 2017 | $1,873,000 | +17.6% | 32,300 | 0.0% | 0.09% | +16.5% |
| Q2 2017 | $1,593,000 | +15.4% | 32,300 | +1.6% | 0.08% | +11.3% |
| Q1 2017 | $1,381,000 | -11.2% | 31,800 | 0.0% | 0.07% | -14.5% |
| Q4 2016 | $1,556,000 | +2.3% | 31,800 | 0.0% | 0.08% | +2.5% |
| Q3 2016 | $1,521,000 | -10.8% | 31,800 | 0.0% | 0.08% | -13.8% |
| Q2 2016 | $1,706,000 | +12.9% | 31,800 | -5.9% | 0.09% | +14.6% |
| Q1 2016 | $1,511,000 | +17.2% | 33,800 | 0.0% | 0.08% | +17.1% |
| Q4 2015 | $1,289,000 | +19.9% | 33,800 | 0.0% | 0.07% | +14.8% |
| Q3 2015 | $1,075,000 | +5.1% | 33,800 | +9.0% | 0.06% | +15.1% |
| Q2 2015 | $1,023,000 | -19.8% | 31,000 | 0.0% | 0.05% | -15.9% |
| Q1 2015 | $1,276,000 | +4.4% | 31,000 | +3.3% | 0.06% | +3.3% |
| Q4 2014 | $1,222,000 | +11.2% | 30,000 | 0.0% | 0.06% | +7.0% |
| Q3 2014 | $1,099,000 | -20.9% | 30,000 | 0.0% | 0.06% | -18.6% |
| Q2 2014 | $1,389,000 | -3.4% | 30,000 | -14.3% | 0.07% | -4.1% |
| Q1 2014 | $1,438,000 | +7.7% | 35,000 | 0.0% | 0.07% | +9.0% |
| Q4 2013 | $1,335,000 | +59.7% | 35,000 | 0.0% | 0.07% | +42.6% |
| Q3 2013 | $836,000 | +40.5% | 35,000 | 0.0% | 0.05% | +30.6% |
| Q2 2013 | $595,000 | – | 35,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
| CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
| Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
| DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
| Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
| Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
| Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
| Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |